BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
3.500
-0.200 (-5.41%)
Jan 19, 2025, 3:49 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $4.94M USD in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $21.99M. In the year 2023, BioLineRx had annual revenue of $4.80M.
Revenue (ttm)
$21.99M
Revenue Growth
n/a
P/S Ratio
0.52
Revenue / Employee
$278.37K
Employees
79
Market Cap
79.00M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 62.35B |
Danel (Adir Yeoshua) | 2.71B |
Kamada | 588.75M |
Bait Bakfar | 102.08M |
Novolog (Pharm-Up 1966) | 1.73B |
Ilex Medical | 982.96M |
BrainsWay | 143.60M |
SofWave Medical | 210.53M |
BioLineRx News
- 4 days ago - BioLineRx announces change to ratio of ADS to ordinary shares - Seeking Alpha
- 4 days ago - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares - PRNewsWire
- 6 days ago - Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
- 15 days ago - Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
- 15 days ago - Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
- 15 days ago - BioLineRx announces $10M registered direct offering; shares tumble - Seeking Alpha
- 15 days ago - BioLineRx Announces $10 Million Registered Direct Offering - PRNewsWire
- 2 months ago - BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript - Seeking Alpha